These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21630454)

  • 1. Quantitative peptidomic analysis by a newly developed one-step direct transfer technology without depletion of major blood proteins: its potential utility for monitoring of pathophysiological status in pregnancy-induced hypertension.
    Araki Y; Nonaka D; Tajima A; Maruyama M; Nitto T; Ishikawa H; Yoshitake H; Yoshida E; Kuronaka N; Asada K; Yanagida M; Nojima M; Yoshida K; Takamori K; Hashiguchi T; Maruyama I; Lee LJ; Tanaka K
    Proteomics; 2011 Jul; 11(13):2727-37. PubMed ID: 21630454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new rapid and comprehensive peptidome analysis by one-step direct transfer technology for 1-D electrophoresis/MALDI mass spectrometry.
    Tanaka K; Tsugawa N; Kim YO; Sanuki N; Takeda U; Lee LJ
    Biochem Biophys Res Commun; 2009 Jan; 379(1):110-4. PubMed ID: 19073144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical peptidomic analysis by a one-step direct transfer technology: its potential utility for monitoring of pathophysiological status in female reproductive system disorders.
    Araki Y; Nonaka D; Hamamura K; Yanagida M; Ishikawa H; Banzai M; Maruyama M; Endo S; Tajima A; Lee LJ; Nojima M; Takamori K; Yoshida K; Takeda S; Tanaka K
    J Obstet Gynaecol Res; 2013 Oct; 39(10):1440-8. PubMed ID: 24033768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced characterization of complex proteomic samples using LC-MALDI MS/MS: exclusion of redundant peptides from MS/MS analysis in replicate runs.
    Chen HS; Rejtar T; Andreev V; Moskovets E; Karger BL
    Anal Chem; 2005 Dec; 77(23):7816-25. PubMed ID: 16316193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple quantitation for potential serum disease biomarker peptides, primarily identified by a peptidomics approach in the serum with hypertensive disorders of pregnancy.
    Hamamura K; Nonaka D; Ishikawa H; Banzai M; Yanagida M; Nojima M; Yoshida K; Lee LJ; Tanaka K; Takamori K; Takeda S; Araki Y
    Ann Clin Biochem; 2016 Jan; 53(Pt 1):85-96. PubMed ID: 25838414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery.
    Koomen JM; Li D; Xiao LC; Liu TC; Coombes KR; Abbruzzese J; Kobayashi R
    J Proteome Res; 2005; 4(3):972-81. PubMed ID: 15952745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative measurement of a candidate serum biomarker peptide derived from α2-HS-glycoprotein, and a preliminary trial of multidimensional peptide analysis in females with pregnancy-induced hypertension.
    Hamamura K; Yanagida M; Ishikawa H; Banzai M; Yoshitake H; Nonaka D; Tanaka K; Sakuraba M; Miyakuni Y; Takamori K; Nojima M; Yoshida K; Fujiwara H; Takeda S; Araki Y
    Ann Clin Biochem; 2018 Mar; 55(2):287-295. PubMed ID: 28656816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semi-targeted plasma proteomics discovery workflow utilizing two-stage protein depletion and off-line LC-MALDI MS/MS.
    Juhasz P; Lynch M; Sethuraman M; Campbell J; Hines W; Paniagua M; Song L; Kulkarni M; Adourian A; Guo Y; Li X; Martin S; Gordon N
    J Proteome Res; 2011 Jan; 10(1):34-45. PubMed ID: 20936781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.
    Lopez MF; Kuppusamy R; Sarracino DA; Prakash A; Athanas M; Krastins B; Rezai T; Sutton JN; Peterman S; Nicolaides K
    J Proteome Res; 2011 Jan; 10(1):133-42. PubMed ID: 20499897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
    West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dansyl-peptides matrix-assisted laser desorption/ionization mass spectrometric (MALDI-MS) and tandem mass spectrometric (MS/MS) features improve the liquid chromatography/MALDI-MS/MS analysis of the proteome.
    Chiappetta G; Ndiaye S; Demey E; Haddad I; Marino G; Amoresano A; Vinh J
    Rapid Commun Mass Spectrom; 2010 Oct; 24(20):3021-32. PubMed ID: 20872635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of protein fragments as pattern features in MALDI-MS analyses of serum.
    Zimmerman LJ; Wernke GR; Caprioli RM; Liebler DC
    J Proteome Res; 2005; 4(5):1672-80. PubMed ID: 16212420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ITI-H4, as a biomarker in the serum of recurrent pregnancy loss (RPL) patients.
    Kim MS; Gu BH; Song S; Choi BC; Cha DH; Baek KH
    Mol Biosyst; 2011 May; 7(5):1430-40. PubMed ID: 21331437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
    Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
    J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Searching biomarker candidates in serum using multidimensional native chromatography. I. Enhanced separation method.
    Kreusch S; Schulze M; Cumme GA; Ditze G; Moore T; Rhode H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(2):567-72. PubMed ID: 18952511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine.
    Terracciano R; Pasqua L; Casadonte F; Frascà S; Preianò M; Falcone D; Savino R
    Bioconjug Chem; 2009 May; 20(5):913-23. PubMed ID: 19338374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum degradome markers for the detection of breast cancer.
    van Winden AW; van den Broek I; Gast MC; Engwegen JY; Sparidans RW; van Dulken EJ; Depla AC; Cats A; Schellens JH; Peeters PH; Beijnen JH; van Gils CH
    J Proteome Res; 2010 Aug; 9(8):3781-8. PubMed ID: 20557135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry.
    van den Broek I; Sparidans RW; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(5-6):590-602. PubMed ID: 20116351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.
    Oh JH; Pan S; Zhang J; Gao J
    Rapid Commun Mass Spectrom; 2010 Feb; 24(4):403-8. PubMed ID: 20069694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.